This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Dividend Yield 5 Year Avg. Replimune has a price-to-earnings (P/E) ratio of -2.06 (TTM). This compares to an industry average of -10.55. What is Replimune’s price-to-book (P/B) ratio? Replimune’s ...